CAPRICOR THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $10.0M | $41.3M | $34.9M |
| FY2022 | $38.3M | $50.1M | $9.6M |
| FY2023 | $36.1M | $58.7M | $14.7M |
| FY2024 | $25.0M | $170.5M | $11.3M |
| FY2025 | $50.2M | $355.9M | $287.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $10.0M | $41.3M | $34.9M |
| FY2022 | $38.3M | $50.1M | $9.6M |
| FY2023 | $36.1M | $58.7M | $14.7M |
| FY2024 | $25.0M | $170.5M | $11.3M |
| FY2025 | $50.2M | $355.9M | $287.8M |